Mineralys Therapeutics Inc
Company Profile
Business description
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.
Contact
150 North Radnor Chester Road
Suite F200
Radnor PA 19087
USAT: +1 888 378-6240
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
28
Stocks News & Analysis
stocks
One of the hottest shares on the ASX reports strong growth
stocks
Diverging value in Australia's real estate sector
stocks
Going into earnings, is Amazon stock a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,094.30 | 111.20 | -1.36% |
| CAC 40 | 7,427.02 | 86.71 | -1.15% |
| DAX 40 | 18,298.72 | 88.74 | -0.48% |
| Dow JONES (US) | 39,935.07 | 81.20 | 0.20% |
| FTSE 100 | 8,186.35 | 32.66 | 0.40% |
| HKSE | 17,004.97 | 306.08 | -1.77% |
| NASDAQ | 17,181.72 | 160.69 | -0.93% |
| Nikkei 225 | 37,869.51 | 1,285.34 | -3.28% |
| NZX 50 Index | 12,396.27 | 134.72 | -1.08% |
| S&P 500 | 5,399.22 | 27.91 | -0.51% |
| S&P/ASX 200 | 7,861.20 | 102.50 | -1.29% |
| SSE Composite Index | 2,886.74 | 15.21 | -0.52% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -3.13% |
| Argosy Minerals Ltd AGY | 0.03 | 0.02 | -30.61% |
| Red 5 Ltd RED | 0.40 | 0.02 | -4.82% |
| Zip Co Ltd ZIP | 1.81 | 0.02 | -0.82% |
| Peninsula Energy Ltd PEN | 0.10 | 0.01 | -4.76% |
| Core Lithium Ltd CXO | 0.09 | 0.00 | -3.19% |
| Medibank Private Ltd MPL | 3.83 | 0.00 | 0.00% |
| Arafura Rare Earths Ltd ARU | 0.17 | 0.03 | -13.16% |
| Syrah Resources Ltd SYR | 0.27 | 0.04 | -11.67% |
| BrainChip Holdings Ltd BRN | 0.21 | 0.01 | 2.50% |